1. Home
  2. STRA vs BCRX Comparison

STRA vs BCRX Comparison

Compare STRA & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STRA

Strategic Education Inc.

HOLD

Current Price

$80.45

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.55

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRA
BCRX
Founded
2017
1986
Country
United States
United States
Employees
N/A
435
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
STRA
BCRX
Price
$80.45
$8.55
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$87.00
$20.82
AVG Volume (30 Days)
206.0K
4.4M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
3.04%
N/A
EPS Growth
15.85
381.40
EPS
1.48
N/A
Revenue
$997,137,000.00
$25,186,000.00
Revenue This Year
$4.71
N/A
Revenue Next Year
$4.67
$12.55
P/E Ratio
$55.08
N/A
Revenue Growth
57.23
N/A
52 Week Low
$69.70
$6.00
52 Week High
$88.50
$10.46

Technical Indicators

Market Signals
Indicator
STRA
BCRX
Relative Strength Index (RSI) 54.14 48.66
Support Level $78.96 $7.95
Resistance Level $84.09 $9.31
Average True Range (ATR) 2.00 0.34
MACD 0.31 -0.01
Stochastic Oscillator 66.33 45.73

Price Performance

Historical Comparison
STRA
BCRX

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: